GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Comprehensive Healthcare Systems CHS.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.32

+6.67%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$4.1m

FY2019FY2025

Net income

−$2.1m

FY2019FY2025

Free cash flow

−$885,122

FY2019FY2025

Shareholders' equity

−$6.2m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue$4.1m$3.8m$3.8m$4.3m$3.2m——
Gross profit$2.4m$2.1m$1.2m$1.4m$960,945——
Research and development$757,586$515,926$488,766$493,818$273,188——
Operating income−$1.8m−$979,637−$3.3m−$5.1m−$1.9m−$51,327−$61,975
Net income−$2.1m−$607,725−$3.6m−$5.1m−$3.5m−$56,756−$75,065
Diluted earnings per share-0.12-0.10-0.58-0.05-0.05-0.03-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$927,299$652,587$972,631$1.5m$2.9m$248,158$227,818
Total liabilities$7.1m$7.1m$6.8m$3.7m$2.5m$10,675$5,159
Debt$58,078$58,076$55,936$604,492———
Shareholders' equity−$6.2m−$6.4m−$5.8m−$2.2m$423,719$237,484$222,659
Shares outstanding18m6m6m104m68m2m2m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−$711,125$366,799−$1.2m−$2.8m−$2.3m−$453,753−$43,426
Capital spending−$173,997−$330,491—−$48,101−$6,890−$3,426—
Free cash flow−$885,122$36,308−$1.2m−$2.8m−$2.3m−$457,179−$43,426

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.2m$1.2m$911,852$1.1m$1.0m$1.0m$947,244$981,805
Gross profit$686,778$712,845$387,661$699,685$632,922$672,749$526,714$562,996
Operating income−$627,564−$529,775−$1.7m−$108,107$12,740$12,348−$637,968$530,742
Net income−$436,723−$494,588−$1.7m−$175,500−$69,332−$155,103−$727,487$456,095
Diluted earnings per share-0.02-0.02-0.10-0.01-0.00-0.01-0.120.07
Cash from operations−$1.0m−$1.0m——————
Total assets$2.6m$2.2m$927,299$885,146$968,975$943,104$652,587$597,880
Debt$1.2m$1.2m$58,078$58,078$58,076$58,077$58,076$655,116
Shareholders' equity−$2.3m−$3.9m−$6.2m−$5.4m−$5.2m−$5.7m−$6.4m−$5.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.4%——
Operating income-30.2%102.6%—
Net income-25.1%106.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin57.0%44.0%——
Operating margin-34.6%-69.7%——
Net margin-34.9%-71.4%——

Valuation history

At each fiscal year end

FY2025FY2024FY2022FY2021FY2020
Price to earnings-3.3-0.1-0.1-0.2-0.4
Price to sales1.70.00.10.2—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 12 May 2025
  • 3.5323-to-1 reverse split · 15 Oct 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.